SaúdeTexto original em inglês
Amylyx experimental drug cuts serious blood sugar events in Phase 3
A Phase 3 trial tested the drug in people with post-bariatric hypoglycemia.
Redigido por IA1 fonte1 min
Loading…
Diagnósticos, próteses, vacinas, genómica: a medicina que ganha anos de vida.
A medicina que ganha anos de vida: rastreios assistidos por IA que examinam milhões de doentes, vacinas de nova geração, uma genómica que passa da sequenciação ao tratamento, próteses e implantes que devolvem capacidades perdidas. A secção segue os ensaios clínicos concluídos, as autorizações de introdução no mercado, as implantações hospitalares — o momento em que uma tecnologia deixa de ser uma publicação para se tornar um cuidado.
Os números mandam: coortes, taxas de deteção, mortalidade evitada, custos. Cobrimos de bom grado os sistemas de saúde que implantam em grande escala — a Índia, o Brasil, o Sudeste Asiático — porque as tecnologias frugais costumam provar-se aí antes de chegarem a outros lugares. Cada artigo apoia-se no ensaio, na autorização ou no estudo que o funda, e cita-os.
A Phase 3 trial tested the drug in people with post-bariatric hypoglycemia.
College students reported less distress after five weeks of emotion-regulation training.
Princeton researchers found music activated brain networks for imagination and meaning.
L-BAIBA helps muscles adapt to exercise and improve their endurance.
About 5% of clear cell ovarian cancers showed high IL-17 activity.
Robotic CABG avoids cutting the breastbone, using small incisions between the ribs.
UCLA’s FLIMPSR reconstructs tissue images from scans with five times lower spatial resolution.
A study of 787 patients identifies tumor removal and treatment timing as survival factors.
ULTRA creates 3D virtual histology of glioma tissue in about 30 minutes.
A mouse study identifies TLR2 as a hub linking inflammation to heart repair.
In preclinical studies, a flexible implant read movement, sensation and organ signals.
Otp helps control stress, thyroid hormones and energy balance in adult mice.
Berkeley Lab scientists linked Huntington’s symptoms to widespread DNA breaks in mouse neurons.
MIT researchers found reusable prefrontal circuits in mice that store different kinds of memories.
Nearly half of patients on 15 mg reached 80% scalp coverage by week 24.
A JN.1-adapted booster improved antibody binding and neutralization.
LTG-001 reduced postsurgical pain more than placebo over 48 hours.
Researchers steered a tiny magnetic screw robot through sheep brain tissue in lab tests.